Table 1.
Summary of patient group data.
| Group | (n =) | Description | Age (Years) | Sex (n =) | |||
|---|---|---|---|---|---|---|---|
| Median | Range | IQR a | M b | F c | |||
| P1 | 18 | therapeutic immunosuppression | 5.7 | 0.7–18.5 | 3.0–12.3 | 4 | 14 |
| C1 | 58 | controls matched to P1 | 6.5 | 0.7–20.2 | 3.7–10.8 | 13 | 45 |
| P2 | 57 | FeLV-infected | 3.9 | 0.4–15.3 | 2.0–8.0 | 35 | 22 |
| C2 | 57 | controls matched to P2 | 4.7 | 0.5–16.0 | 2.7–7.9 | 35 | 22 |
| P3 | 5 | FIV/FeLV-co-infected | 9 | 0.8–12.5 | 2.9–11.3 | 5 | 0 |
| C3 | 39 | controls matched to P3 | 6 | 1.1–16.0 | 3.4–9.3 | 39 | 0 |
| C4 | 21 | historical FIV-infected | 12 | 2.5–17.1 | 8.5–13.7 | 21 | 0 |
a IQR: interquartile range; b M: male; c F: female.